<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28053356</article-id><article-id pub-id-type="pmc">5180337</article-id><article-id pub-id-type="publisher-id">BLT.16.187021</article-id><article-id pub-id-type="doi">10.2471/BLT.16.187021</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorials</subject></subj-group></article-categories><title-group><article-title>Addressing tuberculosis in differentiated care provision for people living with HIV</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Pathmanathan</surname><given-names>Ishani</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pevzner</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cavanaugh</surname><given-names>Joseph</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nelson</surname><given-names>Lisa</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><aff id="aff1"><label>a</label>Division of Global HIV and TB, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, Mailbox E-04, GA, 30329, United States of America (USA).</aff><aff id="aff2"><label>b</label>Office of the Global AIDS Coordinator, Washington, <country>USA</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Ishani Pathmanathan (email: <email xlink:href="ydi6@cdc.gov">ydi6@cdc.gov</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>1</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>01</day><month>1</month><year>2017</year></pub-date><volume>95</volume><issue>1</issue><fpage>3</fpage><lpage>3</lpage><permissions><copyright-statement>(c) 2017 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions></article-meta></front><body><p>Despite advances in prevention, diagnosis and treatment of tuberculosis and human immunodeficiency virus (HIV), tuberculosis remains the leading cause of death and illness among people living with HIV. In 2015, an estimated 1.2 million of the people who developed tuberculosis disease worldwide were HIV positive, and tuberculosis was the direct cause of at least one third of HIV-related deaths.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> The 2015 &#x0201c;Treat All&#x0201d; strategy requires that everyone with HIV is offered antiretroviral therapy (ART) as soon as they are diagnosed. By treating HIV infections earlier, this strategy should mitigate the HIV-associated tuberculosis epidemic, but it alone is not sufficient to eliminate preventable tuberculosis suffering and deaths among people living with HIV.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref> The 2016 World Health Organization (WHO) guidelines recommend differentiated HIV service delivery, which is intended to facilitate the &#x0201c;Treat All&#x0201d; strategy by tailoring services to the differing needs of individuals.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> As HIV programmes adopt these WHO guidelines, tuberculosis also needs to be addressed.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref></p><p>Compared to the general population, people living with HIV have a significantly higher risk of tuberculosis even if they are stable on treatment and have high CD4+ T-lymphocyte counts.<xref rid="R4" ref-type="bibr"><sup>4</sup></xref> Therefore, WHO recommends that all people living with HIV are screened for tuberculosis symptoms (cough of any duration, weight loss, fever or night sweats) at every patient encounter.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> One of the implications of differentiated care is that the intervals between clinic visits and/or antiretroviral pick-ups from pharmacies may be extended to three or six months for people who are stable on ART. However, routine tuberculosis screening is still needed regularly, followed by appropriate evaluation, accurate diagnosis and treatment for either tuberculosis disease or latent infection.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> Patients should also be able to receive tuberculosis preventive therapy at the same time that they pick-up their antiretroviral medications.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref><sup>&#x02013;</sup><xref rid="R7" ref-type="bibr"><sup>7</sup></xref></p><p>As part of differentiated care, community health workers, ART clubs and other models of community service delivery are increasingly being used by HIV-treatment programmes. In these models, participants could be trained to screen for symptoms of tuberculosis and other opportunistic infections, refer people for further evaluation and dispense tuberculosis preventive therapy. This approach has been piloted in several sub-Saharan African settings.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref><sup>&#x02013;</sup><xref rid="R12" ref-type="bibr"><sup>12</sup></xref>
</p><p>In addition, improving participants&#x02019; understanding of tuberculosis will help them to recognize symptoms in themselves and family members and advocate for their own care. Active tuberculosis case-finding among household members and close contacts of tuberculosis patients is critical to finding an estimated 4.3 million people with undiagnosed tuberculosis.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> More collaboration with national tuberculosis programmes is needed to support or expand community- or household-level tuberculosis case-finding activities, such as sputum collection and transport, directly observed therapy, monitoring for adverse events, tracing of people not completing treatment, as well as nutritional support, and health education.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref><sup>&#x02013;</sup><xref rid="R12" ref-type="bibr"><sup>12</sup></xref> Collaboration with civil society organizations will also be needed to understand &#x02013; and adapt service delivery to &#x02013; local context and needs.</p><p>Differentiated care is also expected to make more facility-based resources available to care for patients with advanced and/or unstable disease. For these patients, in addition to the early antiretroviral treatment they should already be receiving, tuberculosis prevention, targeted case-finding and diagnosis are urgently needed. In addition to symptom-screening and rapid diagnostic tests for HIV-associated tuberculosis, supplemental urine lipoarabinomannan testing can be used to diagnose disseminated tuberculosis in the sickest people living with HIV, who are at greatest risk of death.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> As stable patients are managed more in communities, and facilities increasingly become service delivery points for patients with advanced disease, strong infection prevention and control measures are required to prevent iatrogenic transmission of tuberculosis.</p><p>Integrating tuberculosis and HIV activities will allow more people to benefit from the lifesaving potential of the &#x0201c;Treat All&#x0201d; strategy. Differentiated care-delivery systems that account for both tuberculosis and HIV could improve access to services, use existing human resources and supply chains more efficiently and strengthen monitoring and evaluation efforts for both diseases.</p></body><back><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="web">Global tuberculosis report 2015. Geneva: World Health Organization; 2015. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1">http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1</ext-link> [cited 2016 Oct 21].</mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="web">Chiu C. Optimizing South Africa&#x02019;s HIV response: results of the HIV and TB investment case. Abstract 115. Conference on Retroviruses and Opportunistic Infections; 2016 Feb 24; Boston; United States of America. San Francisco: International Antiviral Society&#x02013;USA/CROI Foundation; 2016. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.croiconference.org/sessions/optimising-south-africa%C2%92s-hiv-response-results-hiv-and-tb-investment-case">http://www.croiconference.org/sessions/optimising-south-africa%C2%92s-hiv-response-results-hiv-and-tb-investment-case</ext-link> [cited 2016 Dec 5].</mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="web">Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. Geneva: World Health Organization; 2016. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/hiv/pub/arv/arv-2016/en/">http://www.who.int/hiv/pub/arv/arv-2016/en/</ext-link> [cited 2016 June 13].</mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Gupta</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wood</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kaplan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bekker</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Lawn</surname>
<given-names>SD</given-names></string-name>. <article-title>Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.</article-title>
<source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>3</issue>):<fpage>e34156</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0034156</pub-id><pub-id pub-id-type="pmid">22479548</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Lundgren</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Babiker</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Gordin</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Emery</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Grund</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>; <collab>INSIGHT START Study Group</collab>. <article-title>Initiation of antiretroviral therapy in early asymptomatic HIV infection.</article-title>
<source>N Engl J Med</source>. <year>2015</year>
<month>8</month>
<day>27</day>;<volume>373</volume>(<issue>9</issue>):<fpage>795</fpage>&#x02013;<lpage>807</lpage>.<pub-id pub-id-type="pmid">26192873</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Rangaka</surname>
<given-names>MX</given-names></string-name>, <string-name><surname>Wilkinson</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Boulle</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Glynn</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Fielding</surname>
<given-names>K</given-names></string-name>, <string-name><surname>van Cutsem</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal>
<article-title>Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.</article-title>
<source>Lancet</source>. <year>2014</year>
<month>8</month>
<day>23</day>;<volume>384</volume>(<issue>9944</issue>):<fpage>682</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(14)60162-8</pub-id><pub-id pub-id-type="pmid">24835842</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Uwimana</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zarowsky</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Hausler</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Swanevelder</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Tanana</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Jackson</surname>
<given-names>D</given-names></string-name>. <article-title>Community-based intervention to enhance provision of integrated TB-HIV and MNTCT services in South Africa.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2013</year>;<volume>17</volume>(<issue>10</issue>):<fpage>S48</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.5588/ijtld.13.0173</pub-id><pub-id pub-id-type="pmid">24025379</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Zachariah</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Teck</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Buhendwa</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Labana</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chinji</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Humblet</surname>
<given-names>P</given-names></string-name>, <etal>et al.</etal>
<article-title>How can the community contribute in the fight against HIV/AIDS and tuberculosis? An example from a rural district in Malawi.</article-title>
<source>Trans R Soc Trop Med Hyg</source>. <year>2006</year>
<month>2</month>;<volume>100</volume>(<issue>2</issue>):<fpage>167</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.trstmh.2005.07.008</pub-id><pub-id pub-id-type="pmid">16214192</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Ayles</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Muyoyeta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Du Toit</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Schaap</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Floyd</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Simwinga</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>; <collab>ZAMSTAR team</collab>. <article-title>Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial.</article-title>
<source>Lancet</source>. <year>2013</year>
<month>10</month>
<day>5</day>;<volume>382</volume>(<issue>9899</issue>):<fpage>1183</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)61131-9</pub-id><pub-id pub-id-type="pmid">23915882</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Simon</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chu</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Frieden</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Candrinho</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Ford</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Schneider</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal>
<article-title>An integrated approach of community health worker support for HIV/AIDS and TB care in Ang&#x000f3;nia district, Mozambique.</article-title>
<source>BMC Int Health Hum Rights</source>. <year>2009</year>
<month>7</month>
<day>17</day>;<volume>9</volume>(<issue>1</issue>):<fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/1472-698X-9-13</pub-id><pub-id pub-id-type="pmid">19615049</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="web">Differentiated care for HIV and tuberculosis: A toolkit for health facilities. Geneva: The Global Fund; 2015. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.theglobalfund.org/en/news/2015-12-04_New_Toolkit_for_Differentiated_Care_in_HIV_and_TB_Programs/">http://www.theglobalfund.org/en/news/2015-12-04_New_Toolkit_for_Differentiated_Care_in_HIV_and_TB_Programs/</ext-link> [cited 2016 June 28].</mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="web">Community-based antiretroviral therapy delivery: Experience of M&#x000e9;decins Sans Fronti&#x000e8;res. Geneva: United Nations Programme on HIV/AIDS; 2015. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.unaids.org/sites/default/files/media_asset/20150420_MSF_UNAIDS_JC2707.pdf">http://www.unaids.org/sites/default/files/media_asset/20150420_MSF_UNAIDS_JC2707.pdf</ext-link> [cited 2016 June 28].</mixed-citation></ref></ref-list></back></article>